News Releases

TripleTree iAwards selects eviti for Wireless Health Finalist

Home Home > Homepage > TripleTree iAwards selects eviti for Wireless Health Finalist
| April 25, 2012 |

TripleTree Announces the 2012 iAwards Finalists

Twelve companies are recognized for their innovative wireless health solutions.

Minneapolis, MN – Today, TripleTree announced the 2012 TripleTree iAwards for Wireless Health finalists. Twelve finalists, four in three different categories, were selected from a field of more than 160 nominated companies.

“The number of quality nominations this year is a testament to the growth and maturity of the wireless health industry,” said Chris Hoffmann, Senior Director of Research at TripleTree. “Our judges were challenged in the process of selecting the finalists this year because there were so many exceptional companies and solutions.”

The TripleTree iAwards were created to recognize and reward exceptional companies that are demonstrating insight, innovation, and initiative in the healthcare industry. On an annual basis, nominated companies are judged based upon an evolving set of criteria with a focus on transformative solutions that are shaping the future of healthcare.

The 2012 TripleTree iAwards finalists are:

AwarePoint
Centene Corporation
Consult-a-Doctor
CureMD
Eviti
Fitlinxx
HomeCare HomeBase
Mobile Heartbeat
Optum
Silverlink
Telcare
Watermark Medical

Each of these companies and their wireless health solutions will be featured at the 7th annual Wireless Health Convergence Summit, on May 23-24, 2012, at the Manchester Grand Hyatt in San Diego, where winners in three categories will be announced on May 24th.

Past TripleTree iAward finalists include AirStrip Technologies, BodyMedia, Phreesia, Zeo, CellTrak Technologies, Healthagen, and Epocrates.

About TripleTree

Founded in 1997, TripleTree is an independent, research-driven investment banking firm focused on mergers and acquisitions, financial restructuring, and principal investing advisory services for innovative, high-growth businesses and their investors in the healthcare industry.